newsfilter
← Latest News
GlobeNewswire·

Entrada Therapeutics to Present at Upcoming Investor Conferences

BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (NASDAQ:TRDA), a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape